InMed Pharmaceuticals

IPO: US:INM

Company Description

Clinical stage biotech developing cannabinoid-based products.

Filing Information

File Date

6/19/2020

File Shares

N/A

Low Price Range

N/A

High Price Range

N/A

Proposed Offering Amount

$12,000,000

Exchange

Nasdaq

Underwriter Information

Bookrunner

Roth Capital

Bookrunner

Brookline Capital Markets

Bookrunner

N/A

At a Glance

Company

InMed Pharmaceuticals

Address

City/State

Vancouver, Canada

Phone

N/A

Web

www.inmedpharma.com

Industry

Health-Biotech

Employees

11

Founded

2014

Financial Information

Ltm Date

N/A

Ltm Sales

N/A

Employees

N/A

Use of Proceeds

Clinical trials

IPO Discussion

MarketWatch News on INM

No news currently available
Link to MarketWatch's Slice.